| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |